A number of mechanisms have been put forward to explain the depletion of CD4 cells including cytopathiceffect of the virus, reduced de novo production of T cells and killing of virally infected cells by HIV specificCD8+ T cells. Recently several groups have provided evidence indicating that the best correlate of thedecrease in CD4 numbers is the heightened activation of the immune system. These findings were obtainedboth in the natural history of HIV infection and in primate models showing different disease courses. Themechanisms which lead to this hyperimmune activation are numerous and range from HIV specific effectsincluding the persistent load of antigen, the cytokine storm resulting in increase sensitivity and priming toproapoptotic molecules. An alternative model has recently been proposed and suggests that the disruption ofthe mucosal barrier which can be attributed to the massive infection of the gut by HIV leads to the release ofcommensal bacterial products. These products will in turn activate the dendritic cells and other immune cellsthrough the ligation of Toll like receptors leading potentially to the release of cytokines such as type IInterferons which in turn could upregulate the expression of TRAIL or other mediators of cell death. Ligationof TLRs could stem not only from commensal bacteria but also from HIV itself. Indeed HIV encompassesseveral GU rich sequences which can interact with TLR 7 and also activate dendritic cells to produce type Iinterferons. Ligation of TLR receptors on dendritic cells leads to the upregulation of PDL-1 and PDL-2, theligands on APCs of the PD1 molecule. We and others have recently shown that PD1 is upregulated in cellsfrom HIV infected persons as a result of chronic immune activation. It is hence more than likely that theinteraction of PD-1 with its ligands initiated by the constant engagement of the T cell receptor with Agconcomitantly with and by the ligation of TLRs by HIV GU sequences could lead to the demise of thecapacity of dendritic cells to induce the priming of naTve T cells and the induction of memory CD4 + T cells.We will determine whether aberrant interplay of CD4+ T cells and DC expressing PDL1 and PDL2 will lead totheir functional and physical exhaustion. We will test the hypothesis that elevated levels of PD-1 on CD4+ Tcells and PD-1 ligands on antigen presenting cells are due to the heightened immune activation observed inHIV infection caused by the continuous exposure of DCs to several TLR ligands . Indeed we will define thecontributions of the interplay between the HIV-encoded TLR-7 ligand and other bacterial ligands anddendritic cells on the cellular immune response and in particular the survival and functionality of dendritic celland priming and survival of CD4+ T cells. Altogether our experiments will provide a molecular framework tobridge aberrant DC function and T cell activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI076174-01A1
Application #
7525015
Study Section
Special Emphasis Panel (ZAI1-PRJ-A (J1))
Project Start
2008-08-01
Project End
2013-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
1
Fiscal Year
2008
Total Cost
$371,191
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Castillo-Mancilla, Jose R; Morrow, Mary; Boum, Yap et al. (2018) Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr 77:507-513
Carnathan, Diane; Lawson, Benton; Yu, Joana et al. (2018) Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques. J Virol 92:
Freeman, Michael L; Morris, Stephen R; Lederman, Michael M (2017) CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4+ T Cells. Pathog Immun 2:335-351
Siewe, Basile; Nipper, Allison J; Sohn, Haewon et al. (2017) FcRL4 Expression Identifies a Pro-inflammatory B Cell Subset in Viremic HIV-Infected Subjects. Front Immunol 8:1339
Fu, P; Hughes, J; Zeng, G et al. (2016) A comparative investigation of methods for longitudinal data with limits of detection through a case study. Stat Methods Med Res 25:153-66
Luo, Zhenwu; Ma, Lei; Zhang, Lumin et al. (2016) Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine 34:1945-55
Shive, Carey L; Clagett, Brian; McCausland, Marie R et al. (2016) Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection. J Acquir Immune Defic Syndr 71:483-92
Lee, Sulggi A; Mefford, Joel A; Huang, Yong et al. (2016) Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS 30:1807-15
Pandiyan, Pushpa; Younes, Souheil-Antoine; Ribeiro, Susan Pereira et al. (2016) Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation. Front Immunol 7:228
Siedner, Mark J; Kim, June-Ho; Nakku, Ruth Sentongo et al. (2016) Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis 213:370-8

Showing the most recent 10 out of 90 publications